跳至主要内容
临床试验/NCT01290068
NCT01290068已完成不适用

Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof® ReSTOR IOL Implantation Compared to Monofocal IOL Implantation

Alcon Research0 个研究点目标入组 208 人开始时间: 2011年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
208
主要终点
Percentage of Participants Classified as Responders

研究概览

简要总结

The purpose of this study is to assess and compare visual outcomes of the AcrySof® IQ ReSTOR® +3.0 D intraocular lens (IOL) to a commercially available monofocal IOL in cataract patients.

详细描述

This study included subjects with bilateral age-related cataracts and either no preoperative corneal astigmatism, or preoperative regular corneal astigmatism confirmed by autokeratometry of ≤2.5 D.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to understand and sign an Informed Consent;
  • Willing and able to attend post-operative examinations as per protocol schedule;
  • Diagnosis of bilateral, age-related cataracts;
  • Planned cataract removal via phacoemulsification with implantation of an IOL;
  • Available to undergo second eye surgery within 6 weeks of the first eye surgery;
  • Fulfill the recommendations of the "Warnings" and "Precautions" sections of the AcrySof IQ ReSTOR IOL and Monofocal IOL package inserts;
  • No preoperative corneal astigmatism or preoperative regular corneal astigmatism ≤2.5D;
  • Qualify in both eyes for either AcrySof® IQ ReSTOR® IOL Model SN6AD1 or AcrySof® IQ ReSTOR® Toric IOL Models SND1T2 through SND1T5 as indicated by the AcrySof IQ ReSTOR Multifocal Toric web-based calculator;
  • Able to read and understand one of the following languages: Dutch, French, German, Italian, Spanish, English or Catalan.
  • Other protocol-defined inclusion criteria may apply.

排除标准

  • Previous corneal surgery and/or reshaping;
  • Any abnormality, disease and/or conditions of the cornea (ie, keratoconus, corneal dystrophy, severe keratitis, corneal scar, etc.), which would clinically contraindicate the implantation of a toric IOL;
  • Planned multiple procedures during cataract/IOL implantation surgery;
  • Planned limbal relaxing incisions, excimer laser treatment or similar procedures prior to or during the course of the study;
  • Pregnant, lactating, or planning pregnancy during the course of study;
  • Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

ReSTOR +3

Experimental

AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL, bilateral implantation

干预措施: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL (Device)

ReSTOR +3 Toric

Experimental

AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL, model determined by preoperative corneal astigmatism, bilateral implantation, or implanted in 1 eye with AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL in the other eye

干预措施: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL (Device)

ReSTOR +3 Toric

Experimental

AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL, model determined by preoperative corneal astigmatism, bilateral implantation, or implanted in 1 eye with AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL in the other eye

干预措施: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL (Device)

Monofocal

Active Comparator

Monofocal IOL, bilateral implantation

干预措施: Monofocal IOL (Device)

结局指标

主要结局

Percentage of Participants Classified as Responders

时间窗: Month 6 after second eye implantation

Distance VA and near VA were measured binocularly (both eyes together) without visual correction using ETDRS (Early Treatment of Diabetic Retinopathy Study) charts positioned at a consistent, manufactured distance. VA was measured in logMAR (logarithm of the minimum angle of resolution), with a lower logMAR value indicating better visual acuity. A responder was defined as a participant who achieved bilateral uncorrected distance visual acuity and bilateral uncorrected near visual acuity of ≤0.1 LogMAR at the Month 6 visit.

Mean Vision-Related Quality of Life as Reported on the NEI-RQL 42 (5 Dimensions)

时间窗: Month 6 after second eye implantation

Vision-related quality of life dimensions were evaluated using the National Eye Institute Refractive Error Quality of Life instrument (NEI-RQL 42), a self-administered questionnaire. Each dimension was scored between 0 to 100, with a higher score indicating a better vision-related Quality of Life. 5 of the dimensions were prespecified as primary.

Proportion of Participants Reporting Spectacle Independence at All Distances

时间窗: Month 6 after second eye implantation

Spectacle independence at all distances; ie, where type of spectacles used/prescribed equaled 'No spectacles', was evaluated. If for the 6-month visit, spectacle type information was missing for the spectacle independence endpoint, but the subject attended this 6-month visit, subject was assumed to be spectacle independent.

次要结局

  • Median Total Spectacle Cost Prior to Any Reimbursement(Month 6 after second eye implantation)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验